Ovata Capital Management LTD Tricida, Inc. Transaction History

Ovata Capital Management LTD

  • $91.4 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$7.31 - $11.85 $3,655 - $5,925
-500 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$7.35 - $10.63 $3,675 - $5,315
500 New
500 $4,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email